Literature DB >> 11721973

Second transplantation with CD34+ blood cells from an HLA-mismatched related donor after engraftment failure of transplanted cord blood cells.

H Ohta1, J Y Kim, A Sawada, S Tokimasa, H Fujisaki, Y Matsuda, Y Osugi, J Hara.   

Abstract

Unrelated cord blood transplantation (CBT) has been worldwide for bone marrow reconstitution. CBT is associated with a high frequency of engraftment failure and rejection due to a small dose of graft cells. In cases of engraftment failure or rejection following unrelated CBT, retransplantation from the original donors is impossible. We report a successful transplantation with CD34+ blood cells selected from a 2-loci HLA-mismatched mother to a child with acute monocytic leukemia after engraftment failure of the primary CBT. Selected CD34+ blood cell transplantation is a useful approach for retransplantation in the setting of engraftment failure.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11721973     DOI： 10.1007/bf02982071

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  19 in total

Review 1.  Umbilical cord blood transplants.

Authors:  E Gluckman; F Locatelli
Journal:  Curr Opin Hematol       Date:  2000-11       Impact factor: 3.284

2.  Cord blood transplantation and cord blood bank in Japan.

Authors:  S Kato; H Nishihira; H Hara; K Kato; T Takahashi; N Sato; Y Kodera; H Saito; H Sato; M Takanashi
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

3.  The effect of macrophage colony-stimulating factor on haemopoietic recovery after autologous bone marrow transplantation.

Authors:  A Khwaja; K Yong; H M Jones; R Chopra; A K McMillan; A H Goldstone; K G Patterson; C Matheson; K Ruthven; S B Abramson
Journal:  Br J Haematol       Date:  1992-06       Impact factor: 6.998

Review 4.  Placental/umbilical cord blood transplantation.

Authors:  G Sirchia; P Rebulla
Journal:  Haematologica       Date:  1999-08       Impact factor: 9.941

Review 5.  Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).

Authors:  W Vogel; S Scheding; L Kanz; W Brugger
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

6.  Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.

Authors:  F Aversa; A Terenzi; A Carotti; R Felicini; R Jacucci; T Zei; P Latini; C Aristei; A Santucci; M P Martelli; I Cunningham; Y Reisner; M F Martelli
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

7.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

Authors:  E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

8.  Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group.

Authors:  V Rocha; C Chastang; G Souillet; R Pasquini; E Plouvier; A Nagler; F Locatelli; U Saarinen; G Cornu; F Bernaudin; E Gluckman
Journal:  Bone Marrow Transplant       Date:  1998-06       Impact factor: 5.483

9.  Cord blood transplantation from sibling donors in Japan. Report of the national survey.

Authors:  S Kato; H Nishihira; M Sako; K Kato; E Azuma; Y Kawano; K Kawa; A Kinoshita; K Sugita; Y Sugi; Y Okimoto; T Inamitsu
Journal:  Int J Hematol       Date:  1998-06       Impact factor: 2.490

10.  In vitro and in vivo depletion of T cells.

Authors:  R Arnold; D Bunjes; M Wiesneth; B Hertenstein; M Theobald; H Heimpel; G Hale; H Waldmann
Journal:  Bone Marrow Transplant       Date:  1993       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.